Japan Vitamin K2 Market Size, Share, By Product Type (MK-4 and MK-7), By Formulation (Softgels, Capsules, Tablets, Liquid, and Others), By End Use (Functional Foods & Beverages and Dietary Supplements), By Distribution Channel (Online and Offline), Japan Vitamin K2 Market Insights, Industry Trends, Forecasts to 2035

Japan Vitamin K2 Market Insights Forecasts to 2035

• Japan Vitamin K2 Market Size 2024: USD 17.64 Million
• Japan Vitamin K2 Market Size 2035:  USD 74.52 Million
• Japan Vitamin K2 Market CAGR 2024: 14%
• Japan Vitamin K2 Market Segments: Product Type, Formulation, End Use, and Distribution Channel

Japan vitamin K2 refers to menaquinone compounds of which MK-4 and MK-7 serve as dietary supplements and functional foods that help maintain bone health and heart function and proper blood clotting. The Japanese population uses Vitamin K2 through its distribution in capsules softgels tablets and fortified food products which mainly target senior citizens and people who want to prevent health problems. The product range includes dietary supplements and functional food and beverage products which help maintain bone density and support heart health. The market experiences growth because people become more health conscious and the elderly population increases and there is greater need for preventive nutrition products.

Japan depends on domestic vitamin K2 production and MK-7 imports to fulfil the needs of supplement manufacturers who require these raw materials. The development of new technologies concentrates on creating better fermentation methods which produce high-purity MK-7 and improved stability for fortified beverages and more effective methods for packing substances which enhance their absorption. The regulatory framework establishes safety requirements and quality benchmarks and labeling standards which all nutraceutical products must follow. The company creates potential business growth through its development of functional foods and its production of combined nutraceutical products and premium healthcare items which meet the needs of Japan's aging population and its commitment to long-term health maintenance.

Market Dynamics of the Japan Vitamin K2 Market:

The Japan vitamin K2 market is driven by rising demand for bone and cardiovascular health supplements, supported by Japan’s rapidly aging population and increasing awareness of preventive healthcare. Growing consumer preference for scientifically backed nutraceutical ingredients further strengthens demand for MK-7-based formulations in premium supplements and fortified foods.

Market growth is restrained by strict regulatory standards for health claims and labeling compliance, high product development costs for stabilized formulations, and limited consumer awareness regarding the functional differences between MK-4 and MK-7, which can affect purchasing decisions and brand differentiation.

The market presents opportunities through innovation in high-bioavailability delivery systems, expansion of Vitamin K2 fortification in functional foods and beverages, and development of combination nutraceutical products targeting bone density and cardiovascular support. Increasing online supplement sales and personalized nutrition trends also create long-term growth potential.

Market Segmentation

The Japan vitamin K2 market share is classified into product type, formulation, end use, and distribution channel.

By Product Type:

The Japan vitamin K2 market is divided by product type into MK-4 and MK-7. Among these, the MK-7 segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. Higher bioavailability, longer half-life, improved absorption efficiency, and increasing preference in dietary supplements contribute to MK-7’s dominance and expanded incorporation across functional nutrition formulations in Japan.

By Formulation:

The Japan vitamin K2 market is divided by formulation into softgels, capsules, tablets, liquid, and others. Among these, the softgels segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. Enhanced stability of oil-based ingredients, improved nutrient protection, higher consumer preference for easy swallowing, and superior bioavailability positioning support the softgels segment’s leading market contribution.

By End Use:

The Japan vitamin K2 market is divided by end use into functional foods & beverages and dietary supplements. Among these, the dietary supplements segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period.  Concentrated dosing formats, precise nutrient labeling, controlled intake levels, and strong pharmacy-led distribution channels drive the dietary supplements segment’s dominant revenue contribution.

By Distribution Channel:

The Japan vitamin K2 market is divided by distribution channel into online and offline. Among these, the offline segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. Established pharmacy networks, consumer trust in in-store health consultations, regulated supplement sales environments, and strong retail shelf presence support the offline channel’s sustained market leadership.

Competitive Analysis:

The report offers the appropriate analysis of the key organisations/companies involved within the Japan vitamin K2 market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market. 

Top Key Companies in Japan Vitamin K2 Market:

• J-Oil Mills, Inc.
• Otsuka Pharmaceutical Co., Ltd.
• DHC Corporation
• FANCL Corporation
• Kyowa Hakko Bio Co., Ltd.
• Gnosis by Lesaffre
• Kappa Bioscience
• Novozymes A/S
• BASF SE
• GF Fermentech Co., Ltd.
• Others

Recent Developments in Japan Vitamin K2 Market:

In March 2024, SunWay Biotech and Gnosis by Lesaffre introduced MenaQ7 Metabolic, a new vitamin K2 blend combining MK-7 with ANKASCIN® 568-R, formulated to support bone and heart health through enhanced metabolic positioning.

In February 2025, DSM Firmenich launched an advanced microencapsulation technology designed to protect all-trans menaquinone-7 during high-temperature food processing, enabling improved stability and expanded application of vitamin K2 in fortified foods and nutrition bars.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at the Japan, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Japan vitamin K2 market based on the below-mentioned segments:

Japan Vitamin K2 Market, By Product Type

• MK-4
• MK-7

Japan Vitamin K2 Market, By Formulation

• Softgels
• Capsules
• Tablets
• Liquid
• Others

Japan Vitamin K2 Market, By End Use

• Functional Foods & Beverages
• Dietary Supplements

Japan Vitamin K2 Market, By Distribution Channel

• Online
• Offline